Profile picture

Doctor Marialucia Telesca

Center for Translational and Experimental Cardiology (CTEC), Zurich (Switzerland)
Membership: ESC Professional Member
Follow
Logo ESC

Contributor content

Epigenetic reprogramming of lung fibroblasts drives pulmonary hypertension in obesity-related HFpEF
Presentation
Epigenetic reprogramming of lung fibroblasts drives pulmonary hypertension in obesity-related HFpEF
Paracrine fibroblast–endothelial dialogue promotes pulmonary vascular remodeling in cardiometabolic HFpEF
Presentation
Paracrine fibroblast–endothelial dialogue promotes pulmonary vascular remodeling in cardiometabolic HFpEF
Guido Tarone lecture - Decoding the fibroblast-endothelial dialogue in pulmonary hypertension assiociated with cardiometabolic HFpEF
Presentation
Guido Tarone lecture - Decoding the fibroblast-endothelial dialogue in pulmonary hypertension assiociated with cardiometabolic HFpEF
Therapeutic modulation of the lung microenvironment in obesity-induced heart failure with preserved ejection fraction
Presentation
Therapeutic modulation of the lung microenvironment in obesity-induced heart failure with preserved ejection fraction
The histone methyltransferase SETD2 promotes lipotoxic injury in cardiometabolic heart failure with preserved ejection fraction
Presentation
The histone methyltransferase SETD2 promotes lipotoxic injury in cardiometabolic heart failure with preserved ejection fraction
Employing epi-drugs to rescue lung microenvironmental changes in heart failure with preserved ejection fraction
Presentation
Employing epi-drugs to rescue lung microenvironmental changes in heart failure with preserved ejection fraction
Employing epi-drugs to rescue lung microenvironmental changes in heart failure with preserved ejection fraction
Presentation
Employing epi-drugs to rescue lung microenvironmental changes in heart failure with preserved ejection fraction
Effects of BET Inhibition on lung micro-environmental changes in obesity-related pulmonary Arterial Hypertension (PAH)
Presentation
Effects of BET Inhibition on lung micro-environmental changes in obesity-related pulmonary Arterial Hypertension (PAH)
Sacubitril/valsartan in an experimental model of heart failure with preserved ejection fraction
Presentation
Sacubitril/valsartan in an experimental model of heart failure with preserved ejection fraction